2025 ICD-10 PCS INDEX TERMS STARTING WITH 3

Transfusion Products of Conception, Circulatory to Nonautologous with Factor IX, Percutaneous Approach - 30273W1
Transfusion Products of Conception, Circulatory to Nonautologous with Whole Blood, Via Natural or Artificial Opening Approach - 30277H1
Transfusion Products of Conception, Circulatory to Nonautologous with Serum Albumin, Via Natural or Artificial Opening Approach - 30277J1
Transfusion Products of Conception, Circulatory to Nonautologous with Frozen Plasma, Via Natural or Artificial Opening Approach - 30277K1
Transfusion Products of Conception, Circulatory to Nonautologous with Fresh Plasma, Via Natural or Artificial Opening Approach - 30277L1
Transfusion Products of Conception, Circulatory to Nonautologous with Plasma Cryoprecipitate, Via Natural or Artificial Opening Approach - 30277M1
Transfusion Products of Conception, Circulatory to Nonautologous with Red Blood Cells, Via Natural or Artificial Opening Approach - 30277N1
Transfusion Products of Conception, Circulatory to Nonautologous with Frozen Red Cells, Via Natural or Artificial Opening Approach - 30277P1
Transfusion Products of Conception, Circulatory to Nonautologous with White Cells, Via Natural or Artificial Opening Approach - 30277Q1
Transfusion Products of Conception, Circulatory to Nonautologous with Platelets, Via Natural or Artificial Opening Approach - 30277R1
Transfusion Products of Conception, Circulatory to Nonautologous with Globulin, Via Natural or Artificial Opening Approach - 30277S1
Transfusion Products of Conception, Circulatory to Nonautologous with Fibrinogen, Via Natural or Artificial Opening Approach - 30277T1
Transfusion Products of Conception, Circulatory to Nonautologous with Antihemophilic Factors, Via Natural or Artificial Opening Approach - 30277V1
Transfusion Products of Conception, Circulatory to Nonautologous with Factor IX, Via Natural or Artificial Opening Approach - 30277W1
Transfusion Vein to Nonautologous with 4-Factor Prothrombin Complex Concentrate, Percutaneous Approach - 30283B1
Transfusion Bone Marrow to Autologous with Whole Blood, Percutaneous Approach - 302A3H0
Transfusion Bone Marrow to Nonautologous with Whole Blood, Percutaneous Approach - 302A3H1
Transfusion Bone Marrow to Autologous with Serum Albumin, Percutaneous Approach - 302A3J0
Transfusion Bone Marrow to Nonautologous with Serum Albumin, Percutaneous Approach - 302A3J1
Transfusion Bone Marrow to Autologous with Frozen Plasma, Percutaneous Approach - 302A3K0
Transfusion Bone Marrow to Nonautologous with Frozen Plasma, Percutaneous Approach - 302A3K1
Transfusion Bone Marrow to Autologous with Fresh Plasma, Percutaneous Approach - 302A3L0
Transfusion Bone Marrow to Nonautologous with Fresh Plasma, Percutaneous Approach - 302A3L1
Transfusion Bone Marrow to Autologous with Red Blood Cells, Percutaneous Approach - 302A3N0
Transfusion Bone Marrow to Nonautologous with Red Blood Cells, Percutaneous Approach - 302A3N1
Transfusion Bone Marrow to Autologous with Frozen Red Cells, Percutaneous Approach - 302A3P0
Transfusion Bone Marrow to Nonautologous with Frozen Red Cells, Percutaneous Approach - 302A3P1
Transfusion Bone Marrow to Autologous with Platelets, Percutaneous Approach - 302A3R0
Transfusion Bone Marrow to Nonautologous with Platelets, Percutaneous Approach - 302A3R1
Irrigation None to No Qualifier with Irrigating Substance, External Approach - 3C1ZX8Z
Introduction Skin and Mucous Membranes to Other Antineoplastic with Antineoplastic, External Approach - 3E00X05
Introduction Skin and Mucous Membranes to Monoclonal Antibody with Antineoplastic, External Approach - 3E00X0M
Introduction Skin and Mucous Membranes to Oxazolidinones with Anti-infective, External Approach - 3E00X28
Introduction Skin and Mucous Membranes to Other Anti-infective with Anti-infective, External Approach - 3E00X29
Introduction Skin and Mucous Membranes to No Qualifier with Anti-inflammatory, External Approach - 3E00X3Z
Introduction Skin and Mucous Membranes to No Qualifier with Serum, Toxoid and Vaccine, External Approach - 3E00X4Z
Introduction Skin and Mucous Membranes to No Qualifier with Anesthetic Agent, External Approach - 3E00XBZ
Introduction Skin and Mucous Membranes to Other Substance with Other Therapeutic Substance, External Approach - 3E00XGC
Introduction Skin and Mucous Membranes to No Qualifier with Other Diagnostic Substance, External Approach - 3E00XKZ
Introduction Skin and Mucous Membranes to No Qualifier with Pigment, External Approach - 3E00XMZ
Introduction Skin and Mucous Membranes to No Qualifier with Analgesics, Hypnotics, Sedatives, External Approach - 3E00XNZ
Introduction Skin and Mucous Membranes to No Qualifier with Destructive Agent, External Approach - 3E00XTZ
Introduction Subcutaneous Tissue to Anti-Infective Envelope with Anti-infective, Open Approach - 3E0102A
Introduction Subcutaneous Tissue to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E01305
Introduction Subcutaneous Tissue to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0130M
Introduction Subcutaneous Tissue to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E01328
Introduction Subcutaneous Tissue to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E01329
Introduction Subcutaneous Tissue to Anti-Infective Envelope with Anti-infective, Percutaneous Approach - 3E0132A
Introduction Subcutaneous Tissue to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0133Z
Introduction Subcutaneous Tissue to Influenza Vaccine with Serum, Toxoid and Vaccine, Percutaneous Approach - 3E01340
Introduction Subcutaneous Tissue to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach - 3E0134Z
Introduction Subcutaneous Tissue to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0136Z
Introduction Subcutaneous Tissue to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0137Z
Introduction Subcutaneous Tissue to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E013BZ
Introduction Subcutaneous Tissue to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E013GC
Introduction Subcutaneous Tissue to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E013HZ
Introduction Subcutaneous Tissue to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E013KZ
Introduction Subcutaneous Tissue to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E013NZ
Introduction Subcutaneous Tissue to No Qualifier with Destructive Agent, Percutaneous Approach - 3E013TZ
Introduction Subcutaneous Tissue to Insulin with Hormone, Percutaneous Approach - 3E013VG
Introduction Subcutaneous Tissue to Other Hormone with Hormone, Percutaneous Approach - 3E013VJ
Introduction Muscle to Other Antineoplastic with Antineoplastic, Percutaneous Approach - 3E02305
Introduction Muscle to Monoclonal Antibody with Antineoplastic, Percutaneous Approach - 3E0230M
Introduction Muscle to Oxazolidinones with Anti-infective, Percutaneous Approach - 3E02328
Introduction Muscle to Other Anti-infective with Anti-infective, Percutaneous Approach - 3E02329
Introduction Muscle to No Qualifier with Anti-inflammatory, Percutaneous Approach - 3E0233Z
Introduction Muscle to Influenza Vaccine with Serum, Toxoid and Vaccine, Percutaneous Approach - 3E02340
Introduction Muscle to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach - 3E0234Z
Introduction Muscle to No Qualifier with Nutritional Substance, Percutaneous Approach - 3E0236Z
Introduction Muscle to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach - 3E0237Z
Introduction Muscle to No Qualifier with Anesthetic Agent, Percutaneous Approach - 3E023BZ
Introduction Muscle to Other Substance with Other Therapeutic Substance, Percutaneous Approach - 3E023GC
Introduction Muscle to No Qualifier with Radioactive Substance, Percutaneous Approach - 3E023HZ
Introduction Muscle to No Qualifier with Other Diagnostic Substance, Percutaneous Approach - 3E023KZ
Introduction Muscle to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach - 3E023NZ
Introduction Muscle to No Qualifier with Destructive Agent, Percutaneous Approach - 3E023TZ
Introduction Peripheral Vein to High-dose Interleukin-2 with Antineoplastic, Open Approach - 3E03002
Introduction Peripheral Vein to Low-dose Interleukin-2 with Antineoplastic, Open Approach - 3E03003
Introduction Peripheral Vein to Other Antineoplastic with Antineoplastic, Open Approach - 3E03005
Introduction Peripheral Vein to Monoclonal Antibody with Antineoplastic, Open Approach - 3E0300M
Introduction Peripheral Vein to Clofarabine with Antineoplastic, Open Approach - 3E0300P
Introduction Peripheral Vein to Recombinant Human-activated Protein C with Thrombolytic, Open Approach - 3E03016
Introduction Peripheral Vein to Other Thrombolytic with Thrombolytic, Open Approach - 3E03017
Introduction Peripheral Vein to Oxazolidinones with Anti-infective, Open Approach - 3E03028
Introduction Peripheral Vein to Other Anti-infective with Anti-infective, Open Approach - 3E03029
Introduction Peripheral Vein to No Qualifier with Anti-inflammatory, Open Approach - 3E0303Z
Introduction Peripheral Vein to No Qualifier with Serum, Toxoid and Vaccine, Open Approach - 3E0304Z
Introduction Peripheral Vein to No Qualifier with Nutritional Substance, Open Approach - 3E0306Z
Introduction Peripheral Vein to No Qualifier with Electrolytic and Water Balance Substance, Open Approach - 3E0307Z
Introduction Peripheral Vein to No Qualifier with Intracirculatory Anesthetic, Open Approach - 3E030FZ
Introduction Peripheral Vein to Other Substance with Other Therapeutic Substance, Open Approach - 3E030GC
Introduction Peripheral Vein to Blood Brain Barrier Disruption with Other Therapeutic Substance, Open Approach - 3E030GN
Introduction Peripheral Vein to No Qualifier with Radioactive Substance, Open Approach - 3E030HZ
Introduction Peripheral Vein to No Qualifier with Other Diagnostic Substance, Open Approach - 3E030KZ
Introduction Peripheral Vein to No Qualifier with Analgesics, Hypnotics, Sedatives, Open Approach - 3E030NZ
Introduction Peripheral Vein to No Qualifier with Platelet Inhibitor, Open Approach - 3E030PZ
Introduction Peripheral Vein to No Qualifier with Antiarrhythmic, Open Approach - 3E030RZ
Introduction Peripheral Vein to No Qualifier with Destructive Agent, Open Approach - 3E030TZ
Introduction Peripheral Vein to Autologous with Pancreatic Islet Cells, Open Approach - 3E030U0
Introduction Peripheral Vein to Nonautologous with Pancreatic Islet Cells, Open Approach - 3E030U1